Dania Pagarkar joins Ethics Talk to discuss her article, coauthored with Drs Erin Harrop and Lisa Erlanger: “How Should We Approach Body Size Diversity in Clinical Trials?”
Bias toward allopathic medicine in the research funding and publication of study results makes it difficult for physicians and others to find accurate data about the efficacy of non-Western, nonallopathic treatments.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
Tomas Diaz, MD, Ryan Huerto, MD, MPH, MA, and Jasmine Weiss, MD
Aligning merit-based approaches with holistic approaches and equitable candidate evaluation can improve admissions processes, support learners, and improve patient care.
AMA J Ethics. 2021;23(3):E223-228. doi:
10.1001/amajethics.2021.223.